Asuragen's Series B Round

Asuragen raised a round of funding on December 18, 2007.

Asuragen is a fully integrated molecular diagnostics company focused on oncology and companion diagnostics with special capabilities in the area of mRNA and miRNA. Based in Austin, Texas, the company …

Articles about Asuragen's Series B Round: